Product
Mirvetuximab + SL-172154
Aliases
IMGN853, MIRV
1 clinical trial
6 indications
Indication
Platinum-resistant Ovarian CancerIndication
Fallopian tube cancerIndication
Ovarian CancerIndication
Primary Peritoneal Carcinoma1 clinical trial
6 indications